Elsa U. Pardee Memorial Cancer Lecture
COVID-19 Effects on Cancer Prevention and Screenings
Join Sherri Sheinfeld Gorin, Ph.D., F.S.B.M., research professor, Department of Family Medicine at the University of Michigan School of Medicine, as she presents a community program titled COVID-19, Cancer Prevention and Screening: Impacts and Next Steps.
- The changes in national patterns of cancer screening, treatment and care during and post-pandemic.
- How the pandemic and shelter-in-place orders effected one large, midwestern private medical center.
- The importance of cancer screenings and how COVID-19 has changed screening patterns.
Sherri Sheinfeld Gorin, Ph.D., F.S.B.M.
Dr. Sheinfeld Gorin has held positions of leadership in cancer prevention and control with an emphasis on health disparities over the past 25 years.
Her scholarly interests are both deep and broad. Dr. Sheinfeld Gorin’s primary interests are in the implications of disparities, particularly among ethnic and racial subgroups, in cancer prevention, screening, and treatment outcomes for breast, colorectal, prostate and cervical cancer.
She was among the first to implement randomized clinical trials of office-based academic detailing in cancer prevention and control for physicians serving urban, low-income, minority communities. At present, she is conducting similar studies of the HPV vaccine hesitancy in rural Michigan primary care settings. The published findings have influenced the adoption of academic detailing approaches by local Departments of Health, the American Cancer Society at the national level, and internationally.
Currently, she has a leadership role in an international study to assess behavioral responses to COVID-19 across 190 countries world-wide. She has also contributed to longitudinal studies of Detroit residents’ responses to COVID-19.